TY - JOUR
TI - Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast
Guidelines
AU - Schunemann, Holger J.
AU - Lerda, Donata
AU - Quinn, Cecily
AU - Follmann,
AU - Markus
AU - Alonso-Coello, Pablo
AU - Rossi, Paolo Giorgi
AU - Lebeau,
AU - Annette
AU - Nystrom, Lennarth
AU - Broeders, Mireille and
AU - Ioannidou-Mouzaka, Lydia
AU - Duffy, Stephen W.
AU - Borisch, Bettina and
AU - Fitzpatrick, Patricia
AU - Hofvind, Solveig
AU - Castells, Xavier and
AU - Giordano, Livia
AU - Canelo-Aybar, Carlos
AU - Warman, Sue
AU - Mansel,
AU - Robert
AU - Sardanelli, Francesco
AU - Parmelli, Elena
AU - Grawingholt,
AU - Axel
AU - Saz-Parkinson, Zuleika
AU - ECIBC Contributor Grp
JO - ANNALS OF INTERNAL MEDICINE
PY - 2020
VL - 172
TODO - 1
SP - 46+
PB - AMER COLL PHYSICIANS
SN - 0003-4819
TODO - 10.7326/M19-2125
TODO - null
TODO - Description: The European Commission Initiative for Breast Cancer
Screening and Diagnosis guidelines (European Breast Guidelines) are
coordinated by the European Commission's Joint Research Centre. The
target audience for the guidelines includes women, health professionals,
and policymakers.
Methods: An international guideline panel of 28 multidisciplinary
members, including patients, developed questions and corresponding
recommendations that were informed by systematic reviews of the evidence
conducted between March 2016 and December 2018. GRADE (Grading of
Recommendations Assessment, Development and Evaluation) Evidence to
Decision frameworks were used to structure the process and minimize the
influence of competing interests by enhancing transparency. Questions
and recommendations, expressed as strong or conditional, focused on
outcomes that matter to women and provided a rating of the certainty of
evidence.
Recommendations: This synopsis of the European Breast Guidelines
provides recommendations regarding organized screening programs for
women aged 40 to 75 years who are at average risk. The recommendations
address digital mammography screening and the addition of hand-held
ultrasonography, automated breast ultrasonography, or magnetic resonance
imaging compared with mammography alone. The recommendations also
discuss the frequency of screening and inform decision making for women
at average risk who are recalled for suspicious lesions or who have high
breast density.
ER -